Abstract
Biliary atresia (BA) is a devastating disease of infancy invariably leading, if untreated, to cirrhosis, liver failure and death. It remains the commonest indication for paediatric liver transplantation throughout the developed world and is therefore a leading consumer of resources, despite its rarity.
The aetiology is essentially unknown though it is recognised as consisting of a number of variants with probable diverse actual causes. Though most are isolated anomalies, about 10% are examples of the biliary atresia splenic malformation (BASM) syndrome, with a combination of anomalies, such as polysplenia, situs inversus, malrotation, absence of the vena cava and a preduodenal portal vein.
All cases of BA have pale stools and dark urine and typically present with persisting conjugated jaundice. Diagnosis is by exclusion of medical causes, ultrasound examination and typically, percutaneous liver biopsy. Laparotomy/laparoscopy ± cholangiography will confirm, and in most cases, proceed to a Kasai portoenterostomy (KPE). Clearance of jaundice is possible in ≥50% of infants if performed within 70 days of birth.
For those where this fails and complications supervene or those who present with established end-stage liver disease, then liver transplant should be considered. With this complementary strategy, overall survival is possible in >90% of affected infants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Aldeiri B, Giamouris V, Pushparajah K, Miller O, Baker A, Davenport M (2020, July 20) Cardiac-associated biliary atresia (CABA): a prognostic subgroup. Arch dis child. 106(1):68–72. https://doi.org/10.1136/archdischild-2020-319122. Online ahead of print
Burns J, Davenport M (2020) Adjuvant treatments for biliary atresia. Transl Pediatr 9:253–265. https://doi.org/10.21037/tp.2016.10.08
Davenport M, Tizzard S, Underhill J, Mieli-Vergani G, Portmann B, Hadzic N (2006) The biliary atresia splenic malformation syndrome: a 28-year single-center retrospective study. J Pediatr 149:393–400
Harpavat S, Finegold MJ, Karpen SJ (2011) Patients with biliary atresia have elevated direct/conjugated bilirubin levels shortly after birth. Pediatrics 128(6):e1428–e1433. https://doi.org/10.1542/peds.2011-1869
Harpavat S, Garcia-Prats JA, Anaya C et al (2020) Diagnostic yield of newborn screening for biliary atresia using direct or conjugated bilirubin measurements. JAMA 323(12):1141–1150. https://doi.org/10.1001/jama.2020.0837
Parolini F, Hadzic N, Davenport M (2019) Adjuvant therapy of cytomegalovirus IgM + ve associated biliary atresia: prima facie evidence of effect. J Pediatr Surg 54:1941–1945. https://doi.org/10.1016/j.jpedsurg.2018.12.014
Scottoni F, Davenport M (2020) Biliary atresia: potential for a new decade. Semin Pediatr Surg 29:150940. https://doi.org/10.1016/j.sempedsurg.2020.150940 Epub 2020 Jul 24
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Thompson, H., Davenport, M. (2023). Biliary Atresia. In: Puri, P., Höllwarth, M.E. (eds) Pediatric Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-81488-5_79
Download citation
DOI: https://doi.org/10.1007/978-3-030-81488-5_79
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-81487-8
Online ISBN: 978-3-030-81488-5
eBook Packages: MedicineMedicine (R0)